Australian Senate committee decides against compensation for victims of infected bloodBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7455.1518-f (Published 24 June 2004) Cite this as: BMJ 2004;328:1518
- Bob Burton
An Australian Senate committee of inquiry into the infection of over 8000 people with hepatitis C from blood transfusions and blood products has proposed a fund to improve their access to healthcare services but ruled out a compensation scheme.
Canada and Ireland have instituted compensation schemes covering loss of income and medical costs and—along with Great Britain—the provision of lump sum payments. It was a model that the Senate committee baulked at.
Chairwoman of the committee, Senator Jan McLucas, said: “If we had gone down the route of a compensation tribunal, it is the view of the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial